National Institute of Mental Health; Notice of Closed Meetings

---
identifier: "/us/fr/2024-02045"
source: "fr"
legal_status: "authoritative_unofficial"
title: "National Institute of Mental Health; Notice of Closed Meetings"
title_number: 0
title_name: "Federal Register"
section_number: "2024-02045"
section_name: "National Institute of Mental Health; Notice of Closed Meetings"
positive_law: false
currency: "2024-02-02"
last_updated: "2024-02-02"
format_version: "1.1.0"
generator: "[email protected]"
agency: "Health and Human Services Department"
document_number: "2024-02045"
document_type: "notice"
publication_date: "2024-02-02"
agencies:
  - "Health and Human Services Department"
  - "National Institutes of Health"
fr_citation: "89 FR 7403"
fr_volume: 89
---


#  National Institute of Mental Health; Notice of Closed Meetings

Pursuant to section 1009 of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meetings.

The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.

*Name of Committee:* National Institute of Mental Health Special Emphasis Panel; Precision Mental Health: Develop Tools to Inform Treatment Selection in Depression (UG3/UH3).

*Date:* February 29, 2024.

*Time:* 11:00 a.m. to 4:00 p.m.

*Agenda:* To review and evaluate grant applications.

*Place:* National Institutes of Health, Neuroscience Center, 6001 Executive Boulevard, Rockville, MD 20852.

*Contact Person:* Jasenka Borzan, Ph.D., Scientific Review Officer, Division of Extramural Activities, National Institute of Mental Health, National Institutes of Health, 6001 Executive Blvd., Neuroscience Center, Bethesda, MD 20892, (301) 435-1260, *[email protected]* .

*Name of Committee:* National Institute of Mental Health Special Emphasis Panel; AMP SCZ: Clinical High Risk for Psychosis Clinical Trial Network and DPACC (U01 & U24).

*Date:* February 29, 2024.

*Time:* 12:00 p.m. to 2:00 p.m.

*Agenda:* To review and evaluate grant applications.

*Place:* National Institutes of Health, Neuroscience Center, 6001 Executive Boulevard, Rockville, MD 20852.

*Contact Person:* Rebecca Steiner Garcia, Ph.D., Scientific Review Officer, Division of Extramural Activities, National Institute of Mental Health, National Institutes of Health, Neuroscience Center, 6001 Executive Blvd., Bethesda, MD 20892-9608, 301-443-4525, *[email protected]* .

*Name of Committee:* National Institute of Mental Health Special Emphasis Panel; BRAIN K99.

*Date:* March 6, 2024.

*Time:* 11:00 a.m. to 6:30 p.m.

*Agenda:* To review and evaluate grant applications.

*Place:* National Institutes of Health, Neuroscience Center, 6001 Executive Boulevard, Rockville, MD 20852.

*Contact Person:* EMMA Perez-Costas, Ph.D., Scientific Review Officer, Division of Extramural Activities, National Institute of Mental Health, National Institutes of Health, 6001 Executive Blvd., Rockville, MD 20892, (240) 936-6720, *[email protected]* .

(Catalogue of Federal Domestic Assistance Program No. 93.242, Mental Health Research Grants, National Institutes of Health, HHS)

Dated: January 29, 2024.

Lauren A. Fleck,

Program Analyst, Office of Federal Advisory Committee Policy.